Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Bossi

Showing results (31-40 of 383) with videos related to

Pageof 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2012
How many therapeutic options are there for recurrent or metastatic salivary duct carcinoma?Laura D Locati, Paolo Bossi, Lisa Licitra
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
Palifermin in prevention of head and neck cancer radiation-induced mucositis: not yet a definitive word on safety and efficacy profilePaolo Bossi, Laura D Locati, Lisa Licitra
Oral Oncology|May 26, 2019
May we rely on induction chemotherapy again as a biological selection of radiosensitive head and neck cancer?Paolo Bossi, Emmanuel Seront, Jean Pascal Machiels
Current Opinion in Oncology|March 23, 2006
A multidisciplinary approach to squamous cell carcinomas of the head and neck: what is new?Lisa Licitra, Paolo Bossi, Laura D Locati
Recenti Progressi in Medicina|August 6, 2019
[Description of adverse events in publications of clinical trials: much room for improvement.]Massimo Di Maio, Andrea Antonuzzo, Paolo Bossi
British Journal of Cancer|January 24, 2018
Comment on 'Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer'Paolo Bossi, Roberta Granata, Ester Orlandi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2018
The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluationMichela Meregaglia, John Cairns, Lisa Licitra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2024
Understanding Protective Mechanisms of an Oral Probiotic in Reducing Radiation-Induced Oral MucositisHannah R Wardill, Paolo Bossi, Stephen T Sonis
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 13, 2019
Is pain part of a systemic syndrome in head and neck cancer?Paolo Bossi, Massimo Ghiani, Angela Argenone, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 4, 2021
The impact of the COVID-19 outbreak on supportive care for oral mucositis: current concepts and practicePierluigi Bonomo, Sharon Elad, Tomoko Kataoka, et al.
Pageof 39

Showing results (31-40 of 383) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2012
How many therapeutic options are there for recurrent or metastatic salivary duct carcinoma?Laura D Locati, Paolo Bossi, Lisa Licitra
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
Palifermin in prevention of head and neck cancer radiation-induced mucositis: not yet a definitive word on safety and efficacy profilePaolo Bossi, Laura D Locati, Lisa Licitra
Oral Oncology|May 26, 2019
May we rely on induction chemotherapy again as a biological selection of radiosensitive head and neck cancer?Paolo Bossi, Emmanuel Seront, Jean Pascal Machiels
Current Opinion in Oncology|March 23, 2006
A multidisciplinary approach to squamous cell carcinomas of the head and neck: what is new?Lisa Licitra, Paolo Bossi, Laura D Locati
Recenti Progressi in Medicina|August 6, 2019
[Description of adverse events in publications of clinical trials: much room for improvement.]Massimo Di Maio, Andrea Antonuzzo, Paolo Bossi
British Journal of Cancer|January 24, 2018
Comment on 'Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer'Paolo Bossi, Roberta Granata, Ester Orlandi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2018
The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluationMichela Meregaglia, John Cairns, Lisa Licitra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2024
Understanding Protective Mechanisms of an Oral Probiotic in Reducing Radiation-Induced Oral MucositisHannah R Wardill, Paolo Bossi, Stephen T Sonis
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 13, 2019
Is pain part of a systemic syndrome in head and neck cancer?Paolo Bossi, Massimo Ghiani, Angela Argenone, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 4, 2021
The impact of the COVID-19 outbreak on supportive care for oral mucositis: current concepts and practicePierluigi Bonomo, Sharon Elad, Tomoko Kataoka, et al.
Pageof 39